Proteomics Market: Growth, Size, Share, and Trends

Report Code BT 2341
Published in Feb, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) & Region - Global Forecast to 2029

Overview

The global proteomics market, valued at US$32.98 billion in 2023, stood at US$33.64 billion in 2024 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2029, culminating in a forecasted valuation of US$60.36 billion by the end of the period. The major factors driving growth in the proteomics market are the growing demand for personalized medicines for clinical practices, rising applications in drug discovery and development, growing government & private funding, clinical trial and translational research expansion, biologics and biosimilars development, increasing focus on monoclonal antibodies and therapeutic proteins, and improved techniques in protein quantification. Additionally, advancements in single-cell proteomics and bioinformatics are further driving the growth of the proteomics market.

Proteomics Market

Attractive Opportunities in the Proteomics Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to the presence of a large and growing patient population, increasing demand for innovative therapies, and the emergence of small and mid-sized pharmaceutical companies in the region.

Growth in the proteomics market can mainly be attributed growing demand for personalized medicines for clinical practices, rising application in drug discovery and development and growing government & private funding.

Globally, Asia Pacific grows at a highest CAGR for proteomics and this trend is expected to continue during the forecast period.

Advancement in technology such as mass spectroscopy, chromatography and X-ray crystallography is likely to create lucrative growth opportunities in the market.

Lack of data management/handling in proteomics research is expected to pose a challenge to the growth of this market.

Global Proteomics Market Dynamics

DRIVER: Rising demand for personalized medicine

Proteomics plays an important role in personalized medicine by providing insights at the molecular level. The results make it possible to implement targeted therapies to support individualized medicine through biomarker discovery, identification of drug targets, and follow-up of therapy responses. During the last decade, there has been an increased usage of personalized medicines. In 2021, the FDA's Centre for Drug Evaluation and Research approved 50 novel molecular entities, all but 2 of which were therapeutic goods. Similarly, in 2022, the US FDA approved around 37 NMEs.

RESTRAINT: High cost of instruments

One of the major factors limiting the growth of the proteomics market is the requirement of high investments initially. These are highly sophisticated, fully automated systems, with a relatively high capital expenditure towards procurement, installation, and integration into existing lines of production. This can be very expensive, owing to which raising the stake is quite hard for small and medium-sized enterprises, which form a large part of the manufacturing industry. Although these companies play an important role in product quality and regulatory compliance, steep costs may deter them from adopting essential instruments. Mass spectrometers and chromatography systems are examples of advanced proteomic tools, but they come at a cost. For example, state-of-the-art mass spectrometers run into several hundred thousand dollars—thus posing a considerable expense for research institutions and biotech companies. For example, only reagents for running a single mass spectrometry analysis can be in the range of USD 100–300. The cost in terms of specialists can also run into thousands of dollars a year for institutions if hiring and training are to be done. For small research labs or academic institutions, such expenses are unaffordable.

 

OPPORTUNITY: Advancements in bioinformatics

Advancements in bioinformatics are a key factor driving growth in the proteomics market. Some major technological advancements are software tools for data analysis and interpretation, such as MaxQuant and Proteome Discoverer, that enhance accuracy and speed in identifying and quantifying proteins from mass spectrometry data. Such tools help in the fast, parallel analysis of comprehensive datasets and in predicting the subtle interactions of proteomes and pathways. Technologies in bioinformatics, like computational proteomics and next-generation sequencing technologies, are revolutionizing biological and clinical research. Mass spectrometry allows for high-throughput and exact protein analysis, and NGS allows for fast, inexpensive sequencing of samples to reveal deviations, providing complete transcriptome profiles and identifying microbes. Among the NGS technologies, metagenomic NGS is best suited to detect pathogenic organisms in extremely complex samples. Furthermore, machine learning and artificial intelligence are currently changing the bioinformatics applications in proteomics. For prototyping exact precision in predicting protein structures, functions, and interactions, state-of-the-art algorithms harnessed from artificial intelligence, such as AlphaFold by DeepMind, are increasingly being used. They also empower fast turnaround for designing drug targets and therapeutic molecules.

CHALLENGES: Lack of data management/handling in proteomics research

Although there is a huge volume of proteomics data that is available, the challenge in this market lies in the access and efficient utilization of the same. Poor data management can have a deleterious effect on the outcome of research and may actually turn out to be a growth inhibitor for the market. Recent studies have pointed out that owing to the inefficient handling of data, the use of proteomics data in major applications such as biomarker discovery and drug development has been restricted. For example, researchers in a major biotech company were slowed down while trying to analyze high-throughput proteomics data in the identification of potential therapeutic targets. Such delays slow not only the progress in research but also lengthen the time it takes to translate such discoveries into actionable results, which prolongs the product development cycle. Moreover, the lack of standardization of data formats and lack of interoperability between proteomics platforms make the integration of data from different research initiatives or even institutions very difficult. Besides, high-throughput experiments generate proteomics data that require specialized expertise in processing and analysis. Researchers often invest a huge amount of time in the preprocessing and analysis of proteomics data in order to extract meaningful information. The absence of separation of sample numbers in proteomics repositories makes it extremely hard to formulate the necessary research queries.

Global Proteomics Market Ecosystem Analysis

Proteomics Market
 

The spectroscopy segment dominated the proteomics market in 2023.

The proteomics market is further segmented on the basis of instrumentation technology into spectroscopy, chromatography, mass spectrometry, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. The spectroscopy segment dominated the global proteomics market in 2023 and is likely to continue to do so throughout the forecast period. The growing adoption of spectroscopy techniques in proteomics research is a key factor driving market growth. This is due to their ability to provide valuable insights into protein structure, dynamics, interactions, and functions, among other critical aspects.

The immunoassay reagents segment is poised to exhibit substantial growth at a significant CAGR throughout the forecast period.

The proteomics market is further categorized by reagents into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, protein fractionation reagents, and other reagents. The wide availability of various reagents and the growing demand for reliable, specific, and rapid disease detection at early stages are likely to drive the market growth of immunoassay reagents.

North America dominated the global proteomics market in 2023.

Based on region, the proteomics market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global proteomics market in 2023 and is likely to dominate throughout the forecast period. The presence of many pharmaceutical companies and the rising demand for precision medicines are likely to boost the market in the region. Additionally, the rising research funding further drives the growth of the proteomics market in North America.

NORTH AMERICA COMMANDED HIGHEST MARKET SHARE IN 2023
US IS THE FASTEST-GROWING REGION
Proteomics Market

Recent Developments of Proteomics Market

  • In October 2024, Thermo Fisher launched Thermo Scientific iCAP MX Series ICP-MS, which includes a new single quadrupole Thermo Scientific iCAP MSX ICP-MS and triple quadrupole Thermo Scientific iCAP MTX ICP-MS to analyze routine and challenging trace elements to detect and mitigate harmful substances.
  • In October 2024 Agilent Technologies launched next generation InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, allowing labs to focus more on achieving results rather than on daily operation and maintenance tasks.
  • In October 2023, Thermo Fisher Scientific Inc (US) acquired Olink Holdings (Sweden) with an aim to enhance Thermo Fisher’s capabilities in the high-growth proteomics market.
  • In June 2024, Agilent Technologies, Inc. (US) launched two new products, the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell available for the 6545XT AdvanceBio LC/Q-TOF, at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics to advance gas chromatography-mass spectrometry (GC/MS) and LC/Q-TOF technology.
  • In June 2024, Danaher Corporation (US) and Mass Analytica (Spain) collaborated to reveal artificial intelligence quantitation (AI quant) software, which offers high-resolution MS/MS analysis with an intelligent fragment selection algorithm.
  • In February 2023, Waters Corporation (US) acquired Wyatt Technology (US), which enhanced the portfolio of separation and detection and provided customers with an unmatched set of analytical solutions across a wide range of applications.

Key Market Players

KEY PLAYERS IN THE PROTEOMICS MARKET INCLUDE

Scope of the Report

Report Metric Details
Market size available for years 2023-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD)
Segments covered Product, Reagent, Service, Application, End User, and region
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Key Questions Addressed by the Report

Who are the key players in the proteomics market?

The key players in the market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), and Waters Corporation (US).

Which technology segment dominates the proteomics market?

The spectroscopy segment accounted for the largest share of the market in 2023.

Which reagent segment dominates the proteomics market?

The immunoassay reagents segment accounted for the largest share of the proteomics market in 2023.

What is the size of the proteomics market?

The proteomics market is expected to reach USD 60.36 billion by 2029 from USD 33.64 billion in 2024.

What is the estimated growth rate (CAGR) of the proteomics market?

The global proteomics market size has an estimated CAGR of 12.4%.

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Proteomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
56
RESEARCH METHODOLOGY
61
EXECUTIVE SUMMARY
74
PREMIUM INSIGHTS
80
MARKET OVERVIEW
Discover the Market Dynamics and Upcoming Trends Shaping the Proteomics Market
84
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing demand for personalized medicines in clinical practices
    - High investments in pharmaceutical R&D
    - Rising applications in drug discovery and development
    - Increased private and government funding
    RESTRAINTS
    - High costs of proteomics instruments and technologies
    - Lack of standardization
    OPPORTUNITIES
    - Advancements in bioinformatics
    - Developments in single-cell proteomics research
    - Increasing number of collaborations and strategic partnerships
    CHALLENGES
    - Lack of data management and handling
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Mass spectrometry
    - Chromatography
    - Protein microarrays
    COMPLEMENTARY TECHNOLOGIES
    - Transcriptomics
    - Metabolomics
    ADJACENT TECHNOLOGIES
    - Single-cell proteomics
  • 5.5 PRICING ANALYSIS
    INDICATIVE SELLING PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021–2023
    AVERAGE SELLING PRICE TREND OF PROTEOMICS INSTRUMENTS, BY REGION, 2023
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
    PROTEOMICS PRODUCT AND SERVICE PROVIDERS
    END USERS
    REGULATORY BODIES
  • 5.9 PATENT ANALYSIS
    METHODOLOGY
    NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2013–2024
    INNOVATION AND PATENT APPLICATION
    TOP TEN PLAYERS WITH HIGHEST NUMBER OF APPLICATIONS
    TOP 10 PATENT OWNERS
    KEY PATENTS IN PROTEOMICS MARKET
  • 5.10 TRADE ANALYSIS
    IMPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)
    EXPORT DATA FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720)
    IMPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781)
    EXPORT DATA FOR MASS SPECTROMETERS (HS CODE: 902781)
  • 5.11 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.12 REGULATORY LANDSCAPE
    REGULATORY SCENARIO
    - North America
    - Europe
    - Asia Pacific
    - Rest of the world
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13 INVESTMENT AND FUNDING SCENARIO
  • 5.14 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.16 IMPACT OF AI/GEN AI ON PROTEOMICS MARKET
PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY
Detailed Market Analysis of Proteomics Instrumentation Technology: Market Size (2022-2029) & Forecast To 2029 – Value USD Million
124
  • 6.1 INTRODUCTION
  • 6.2 SPECTROSCOPY
    MASS SPECTROMETRY
    - High specificity and technological advancements to propel segment growth
    NMR SPECTROSCOPY
    - Accurate evaluation of physical, chemical, electronic, and structural information of proteins to aid segment growth
    CD SPECTROSCOPY
    - Non-destructive and non-invasive techniques to examine changes in secondary protein structures
  • 6.3 CHROMATOGRAPHY
    HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
    - High resolution, sensitivity, and reproducibility to spur segment growth
    ION CHROMATOGRAPHY
    - High resolving power, simplicity, and controllability to separate and purify proteins
    AFFINITY CHROMATOGRAPHY
    - High specificity for target proteins and easy identification of novel protein interactions to drive segment
    SUPERCRITICAL FLUID CHROMATOGRAPHY
    - Ability to separate complex protein mixtures with high efficiency and speed to fuel segment growth
  • 6.4 ELECTROPHORESIS
    GEL ELECTROPHORESIS
    - Increasing demand for proteomics research and personalized medicine to boost segment growth
    CAPILLARY ELECTROPHORESIS
    - Low diffusion coefficients of biomolecules and easy elimination of sample carryover between measurements to drive market
  • 6.5 PROTEIN MICROARRAYS
    BIOCHIPS
    - Lab-on-chips
    - Protein chips
    MICROARRAY INSTRUMENTS
    - Integrated systems
    - Microarray scanners
    - Arrayers
  • 6.6 X-RAY CRYSTALLOGRAPHY
    RISING NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES TO AUGMENT MARKET GROWTH
  • 6.7 SURFACE PLASMON RESONANCE
    INCREASING ABILITY TO BIND AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET GROWTH
  • 6.8 PROTEIN FRACTIONATION
    PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF PROTEINS IN COMPLEX MIXTURES
  • 6.9 OTHER INSTRUMENTATION TECHNOLOGIES
PROTEOMICS MARKET, BY REAGENT
Detailed Market Analysis of Proteomics Reagents: Market Size (2022-2029) & Forecast To 2029 – Value USD Million
225
  • 7.1 INTRODUCTION
  • 7.2 IMMUNOASSAY REAGENTS
    NEED FOR RELIABLE, SPECIFIC, AND FAST DISEASE DETECTION AT EARLY STAGES TO FAVOR MARKET GROWTH
  • 7.3 SPECTROSCOPY REAGENTS
    INCREASED ADOPTION OF HIGH-THROUGHPUT MASS SPECTROSCOPY-BASED TECHNIQUES TO AID MARKET GROWTH
  • 7.4 CHROMATOGRAPHY REAGENTS
    BETTER ACCURACY AND LOWER DETECTION LIMITS TO FACILITATE SEGMENT GROWTH
  • 7.5 PROTEIN MICROARRAY REAGENTS
    DEVELOPMENT OF NOVEL AND ADVANCED PROTEIN ANALYSIS REAGENTS TO PROPEL MARKET GROWTH
  • 7.6 X-RAY CRYSTALLOGRAPHY REAGENTS
    EMERGENCE OF NEW TARGETS FOR DRUG DISCOVERY AND HIGH R&D INVESTMENTS TO SUPPORT MARKET GROWTH
  • 7.7 ELECTROPHORESIS REAGENTS
    INCREASING DEMAND FOR 2D ELECTROPHORESIS TO AUGMENT MARKET GROWTH
  • 7.8 PROTEIN FRACTIONATION REAGENTS
    RISING NEED FOR PROTEIN FRACTIONATION TECHNIQUES TO AUGMENT MARKET GROWTH
  • 7.9 OTHER REAGENTS
PROTEOMICS MARKET, BY SERVICE
Detailed Market Analysis of Proteomics Services: Market Size (2022-2029) & Forecast To 2029 – Value USD Million
261
  • 8.1 INTRODUCTION
  • 8.2 CORE PROTEOMICS SERVICES
    PROTEIN IDENTIFICATION SERVICES
    - Rising need for protein identification and molecular weight analysis to boost market growth
    QUANTITATIVE PROTEOMICS SERVICES
    - Rapid and low-cost alternatives to help understand global protein expression and modifications
    PROTEIN CHARACTERIZATION SERVICES
    - Characterization studies to help study complex protein structure, drug development, and PTMs
    PROTEIN PURIFICATION SERVICES
    - Protein purification to maximize yield and purity of protein of interest
    PROTEIN SEPARATION SERVICES
    - Technological advancements and use in downstream applications to augment segment growth
    PROTEIN SEQUENCING SERVICES
    - Identification and characterization of PTMs to favor protein sequencing and research
    CUSTOM ASSAY SERVICES
    - Custom assays to improve validation or consistency of protein analysis procedures
  • 8.3 BIOINFORMATICS SERVICES
    LESSER ANALYSIS TIME AND FAVORABLE GOVERNMENT INITIATIVES TO SPUR MARKET GROWTH
PROTEOMICS MARKET, BY SOFTWARE
Detailed Market Analysis of Proteomics Software: Market Size (2022-2029) & Forecast To 2029 – Value USD Million
301
  • 9.1 INTRODUCTION
    BIOINFORMATICS TOOLS
    - Need for data management and advancements in bioinformatics to augment market growth
    BIOINFORMATICS DATABASES
    - Need to store proteomics data and integrate other omics databases to drive market
PROTEOMICS MARKET, BY APPLICATION
Detailed Analysis of Proteomics Application Market: Market Size (2022-2029) & Forecast To 2029 – Value USD Million
312
  • 10.1 INTRODUCTION
  • 10.2 CLINICAL DIAGNOSTICS
    CANCER
    - Rising prevalence of cancer to propel market growth
    INFECTIOUS DISEASES
    - Technological advancements and need for effective disease diagnosis to support market growth
    DIABETES
    - Need for advanced diagnostic technologies and high diabetes prevalence to aid market growth
    NEUROLOGICAL DISORDERS
    - Growing target patient population and increasing research grants to fuel market growth
    AUTOIMMUNE DISEASES
    - Increasing patient population and growing focus on immunology-based research to propel market growth
    CARDIOVASCULAR DISEASES
    - High burden of cardiovascular diseases to spur adoption of reliable diagnostic tools
    OTHER CLINICAL DIAGNOSTIC APPLICATIONS
  • 10.3 DRUG DISCOVERY & DEVELOPMENT
    TARGET DISCOVERY
    - Increased demand for personalized medicine to support segment growth
    LEAD IDENTIFICATION
    - Lead identification to be essential in drug discovery and characterization
    LEAD OPTIMIZATION
    - Need for optimizing drug efficacy and safety to spur segment growth
    PRECLINICAL STUDIES
    - Integration of proteomics in preclinical studies to refine drug safety and efficacy
  • 10.4 OTHER APPLICATIONS
PROTEOMICS MARKET, BY END USER
Detailed End User-Specific Analysis of Proteomics Market: Market Size (2022-2029) & Forecast To 2029 – Value USD Million
371
  • 11.1 INTRODUCTION
  • 11.2 BIOPHARMACEUTICAL COMPANIES
    LOW OPERATING COSTS AND RAPID DRUG ANALYSIS TO DRIVE MARKET
  • 11.3 ACADEMIC AND RESEARCH INSTITUTES
    INCREASING RESEARCH FUNDING FOR PRECISION MEDICINE TO BOOST MARKET GROWTH
  • 11.4 HOSPITALS
    GROWING PREVALENCE OF IMMUNODEFICIENCY DISEASES AND SERUM PROTEIN DISORDERS TO BOOST MARKET GROWTH
  • 11.5 CLINICAL LABORATORIES
    INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO SUPPORT MARKET GROWTH
  • 11.6 OTHER END USERS
PROTEOMICS MARKET, BY REGION
Region and Country-level Analysis of Proteomics Market: Market Size (2022-2029) & Forecast To 2029 – Value USD Million
394
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American proteomics market during study period
    CANADA
    - Favorable government initiatives and high incidence of cancer to support market growth
  • 12.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Well-established pharmaceutical industry and increased government funding to augment market growth
    UK
    - Developed life science industry and increased academia-industry partnerships to augment market growth
    FRANCE
    - High investments in life science R&D and increased demand for personalized therapeutics to aid market growth
    SWITZERLAND
    - Well-established pharmaceutical and biotechnology industry and increased investments in life science R&D to drive market
    ITALY
    - High private and public R&D funding and favorable government initiatives to favor market growth
    SPAIN
    - Well-established network of research centers, universities, and hospitals to aid market growth
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Rising government R&D investments and increasing focus on healthcare product manufacturing to fuel market growth
    JAPAN
    - Large geriatric population and strong pharmaceutical research base to drive market
    INDIA
    - Increasing focus on proteomics and genomic research to support market growth
    SOUTH KOREA
    - Developed medical tourism and advanced healthcare infrastructure to propel market growth
    AUSTRALIA
    - Favorable government initiatives and high R&D investments to favor market growth
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Increasing contract research and manufacturing activities to drive market
    MEXICO
    - Strong pharmaceutical industry and increased government support to augment market growth
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    GCC COUNTRIES
    - Saudi Arabia
    - UAE
    - Rest of GCC Countries
    REST OF MIDDLE EAST
  • 12.7 AFRICA
    FAVORABLE GOVERNMENT INITIATIVES AND ADVANCEMENTS IN PERSONALIZED MEDICINES TO PROPEL MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR AFRICA
COMPETITIVE LANDSCAPE
Market Share Analysis (%), Revenue Analysis (USD Million) & Competitive Positioning Matrix
634
  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET
  • 13.3 REVENUE ANALYSIS, 2021–2023
  • 13.4 MARKET SHARE ANALYSIS, 2023
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Instrumentation technology footprint
    - Reagent footprint
    - Service footprint
    - Software footprint
    - Region footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 13.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
In-Depth Profiles of Key Players and SMEs/Start-ups with Business Overview, Financials, Portfolio, Recent Developments
656
  • 14.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services/Solutions offered
    RECENT DEVELOPMENTS
    - Product launches
    - Deals
    - MnM view
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products/Services/Solutions offered
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    SHIMADZU CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    WATERS CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BRUKER
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    REVVITY
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ILLUMINA, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    PROMEGA CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    EUROFINS SCIENTIFIC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    QIAGEN
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    CHARLES RIVER LABORATORIES
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    PROTAGENE
    - Business overview
    - Products/Services/Solutions offered
  • 14.2 OTHER PLAYERS
    CREATIVE PROTEOMICS, US
    HORIBA JAPAN LTD.
    SENGENICS CORPORATION LLC
    LABVANTAGE-BIOMAX GMBH
    FIOS GENOMICS
    AZENTA US, INC.
    MEDGENOME
    BIOGNOSYS AG
    MACROGEN, INC.
    CELL SIGNALING TECHNOLOGY, INC.
APPENDIX
789
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 PROTEOMICS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
  • TABLE 3 PROTEOMICS MARKET: RISK ANALYSIS
  • TABLE 4 INDICATIVE PRICE TREND FOR PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2021–2023 (USD)
  • TABLE 5 PROTEOMICS PRODUCT AND SERVICE PROVIDERS: ROLE IN ECOSYSTEM
  • TABLE 6 END USERS: ROLE IN ECOSYSTEM
  • TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM
  • TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, JANUARY 2013–AUGUST 2024
  • TABLE 9 PROTEOMICS MARKET: TOP 10 PATENT OWNERS, 2013–2023
  • TABLE 10 KEY PATENTS IN PROTEOMICS MARKET, 2021–2024
  • TABLE 11 IMPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019–2023 (TON)
  • TABLE 12 EXPORT VOLUME FOR CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS (HS CODE: 902720), 2019–2023 (TON)
  • TABLE 13 IMPORT VOLUME FOR MASS SPECTROMETERS (HS CODE: 902781), 2022–2023 (USD)
  • TABLE 14 EXPORT VOLUME FOR MASS SPECTROMETERS (HS CODE-902781), 2022–2023 (USD)
  • TABLE 15 PROTEOMICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
  • TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 PROTEOMICS MARKET: IMPACT OF PORTER’S FIVE FORCES
  • TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 22 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 23 PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 24 PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 25 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 29 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 MASS SPECTROMETRY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 32 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 MIDDLE EAST: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 NMR SPECTROSCOPY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 MIDDLE EAST: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 GCC COUNTRIES: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 CD SPECTROSCOPY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 MIDDLE EAST: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 GCC COUNTRIES: CD SPECTROSCOPY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 53 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 EUROPE: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 LATIN AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 MIDDLE EAST: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 GCC COUNTRIES: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 ION CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 MIDDLE EAST: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 GCC COUNTRIES: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 75 NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 MIDDLE EAST: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 GCC COUNTRIES: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 MIDDLE EAST: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 GCC COUNTRIES: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 89 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 GEL ELECTROPHORESIS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 MIDDLE EAST: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 GCC COUNTRIES: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 104 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 MIDDLE EAST: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 GCC COUNTRIES: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 BIOCHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 LATIN AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 MIDDLE EAST: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 125 GCC COUNTRIES: BIOCHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 LAB-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 130 LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 MIDDLE EAST: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 GCC COUNTRIES: LAB-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 PROTEIN CHIPS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 137 LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 MIDDLE EAST: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 GCC COUNTRIES: PROTEIN CHIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 MICROARRAY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 142 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 INTEGRATED SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 149 NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 152 LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 MIDDLE EAST: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 GCC COUNTRIES: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 MICROARRAY SCANNERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 156 NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 159 LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 MIDDLE EAST: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 GCC COUNTRIES: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 162 ARRAYERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 163 NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 EUROPE: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 166 LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 168 GCC COUNTRIES: ARRAYERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 169 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 177 NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 178 EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 MIDDLE EAST: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 182 GCC COUNTRIES: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 183 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 184 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 188 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 191 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 EUROPE: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 193 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 195 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 196 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 PROTEOMICS MARKETS, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 198 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 199 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 200 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 203 MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 206 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 207 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 210 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 213 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 220 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 221 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 224 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 226 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 227 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 229 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 231 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 232 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 233 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 234 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 238 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 240 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 241 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 244 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 247 PROTEOMICS MARKET FOR OTHER REAGENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 248 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 249 EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 251 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 252 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 254 PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 255 CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 CORE PROTEOMICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 257 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 258 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 260 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 261 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 263 PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 264 NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 265 EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 266 ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 267 LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 268 MIDDLE EAST: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 269 GCC COUNTRIES: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 270 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 271 NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 272 EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 273 ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 274 LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 275 MIDDLE EAST: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 276 GCC COUNTRIES: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 277 PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 278 NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 279 EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 280 ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 281 LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2022–2029 (USD MILLION)
  • TABLE 282 MIDDLE EAST: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 283 GCC COUNTRIES: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 284 PROTEIN PURIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 285 NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 286 EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 287 ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 288 LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 289 MIDDLE EAST: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 290 GCC COUNTRIES: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 291 PROTEIN SEPARATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 292 NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 293 EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 295 LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 296 MIDDLE EAST: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 297 GCC COUNTRIES: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 298 PROTEIN SEQUENCING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 299 NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 300 EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 301 ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 302 LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 303 MIDDLE EAST: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 304 GCC COUNTRIES: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 305 CUSTOM ASSAY SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 306 NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 307 EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 308 ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 309 LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 310 MIDDLE EAST: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 311 GCC COUNTRIES: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 312 BIOINFORMATICS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 313 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 314 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 315 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 316 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 317 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 318 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 319 PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 320 PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 321 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 322 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 324 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 325 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 326 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 327 PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 328 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 329 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 330 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 331 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 332 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 333 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 334 PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 335 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 337 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 338 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 340 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 341 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 342 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 343 CANCER MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 344 NORTH AMERICA: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 345 EUROPE: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 346 ASIA PACIFIC: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 347 LATIN AMERICA: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 348 MIDDLE EAST: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 349 GCC COUNTRIES: CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 350 INFECTIOUS DISEASES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 351 NORTH AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 352 EUROPE: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 353 ASIA PACIFIC: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 354 LATIN AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 355 MIDDLE EAST: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 356 GCC COUNTRIES: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 357 DIABETES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 358 NORTH AMERICA: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 359 EUROPE: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 360 ASIA PACIFIC: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 361 LATIN AMERICA: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 362 MIDDLE EAST: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 363 GCC COUNTRIES: DIABETES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 364 NEUROLOGICAL DISORDERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 365 NORTH AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 366 EUROPE: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 367 ASIA PACIFIC: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 368 LATIN AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 369 MIDDLE EAST: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 370 GCC COUNTRIES: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 371 AUTOIMMUNE DISEASES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 372 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 373 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 374 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 375 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 376 MIDDLE EAST: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 377 GCC COUNTRIES: PROTEOMICS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 378 CARDIOVASCULAR DISEASES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 379 NORTH AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 380 EUROPE: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 381 ASIA PACIFIC: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 382 LATIN AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 383 MIDDLE EAST: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 384 GCC COUNTRIES: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 385 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 386 NORTH AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 387 EUROPE: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 388 ASIA PACIFIC: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 389 LATIN AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 390 MIDDLE EAST: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 391 GCC COUNTRIES: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 392 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 393 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 394 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 395 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 396 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 397 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 398 MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 399 GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 400 TARGET DISCOVERY MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 401 NORTH AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 402 EUROPE: TARGET DISCOVERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 403 ASIA PACIFIC: TARGET DISCOVERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 404 LATIN AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 405 MIDDLE EAST: TARGET DISCOVERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 406 GCC COUNTRIES: TARGET DISCOVERY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 407 LEAD IDENTIFICATION MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 408 NORTH AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 409 EUROPE: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 410 ASIA PACIFIC: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 411 LATIN AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 412 MIDDLE EAST: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 413 GCC COUNTRIES: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 414 LEAD OPTIMIZATION MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 415 NORTH AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 416 EUROPE: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 417 ASIA PACIFIC: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 418 LATIN AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 419 MIDDLE EAST: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 420 GCC COUNTRIES: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 421 PRECLINICAL STUDIES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 422 NORTH AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 423 EUROPE: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 424 ASIA PACIFIC: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 425 LATIN AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 426 MIDDLE EAST: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 427 GCC COUNTRIES: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 428 PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 429 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 430 EUROPE: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 431 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 432 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 433 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 434 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 435 PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 436 PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 437 NORTH AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 438 EUROPE: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 439 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 440 LATIN AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 441 MIDDLE EAST: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 442 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 443 PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 444 NORTH AMERICA: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 445 EUROPE: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 446 ASIA PACIFIC: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 447 LATIN AMERICA: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 448 MIDDLE EAST: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 449 GCC COUNTRIES: PROTEOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 450 PROTEOMICS MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 451 NORTH AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 452 EUROPE: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 453 ASIA PACIFIC: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 454 LATIN AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 455 MIDDLE EAST: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 456 GCC COUNTRIES: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 457 PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 458 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 459 EUROPE: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 460 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 461 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 462 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 463 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 464 PROTEOMICS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 465 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 466 EUROPE: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 467 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 468 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 469 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 470 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 471 PROTEOMICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 472 NORTH AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 473 NORTH AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 474 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 475 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 476 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 477 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 478 NORTH AMERICA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 479 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 480 NORTH AMERICA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 481 NORTH AMERICA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 482 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 483 NORTH AMERICA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 484 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 485 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 486 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 487 NORTH AMERICA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 488 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 489 US: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 490 US: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 491 US: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 492 US: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 493 US: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 494 US: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 495 US: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 496 US: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 497 US: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 498 US: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 499 US: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 500 US: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 501 US: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 502 US: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 503 US: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 504 CANADA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 505 CANADA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 506 CANADA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 507 CANADA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 508 CANADA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 509 CANADA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 510 CANADA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 511 CANADA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 512 CANADA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 513 CANADA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 514 CANADA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 515 CANADA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 516 CANADA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 517 CANADA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 518 CANADA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 519 EUROPE: PROTEOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 520 EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 521 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 522 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 523 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 524 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 525 EUROPE: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 526 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 527 EUROPE: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 528 EUROPE: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 529 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 530 EUROPE: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 531 EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 532 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 534 EUROPE: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 535 EUROPE: KEY MACROINDICATORS
  • TABLE 536 GERMANY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 537 GERMANY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 538 GERMANY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 539 GERMANY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 540 GERMANY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 541 GERMANY: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 542 GERMANY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 543 GERMANY: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 544 GERMANY: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 545 GERMANY: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 546 GERMANY: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 547 GERMANY: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 548 GERMANY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 549 GERMANY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 550 GERMANY: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 551 UK: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 552 UK: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 553 UK: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 554 UK: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 555 UK: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 556 UK: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 557 UK: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 558 UK: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 559 UK: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 560 UK: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 561 UK: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 562 UK: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 563 UK: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 564 UK: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 565 UK: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 566 FRANCE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 567 FRANCE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 568 FRANCE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 569 FRANCE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 570 FRANCE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 571 FRANCE: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 572 FRANCE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 573 FRANCE: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 574 FRANCE: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 575 FRANCE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 576 FRANCE: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 577 FRANCE: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 578 FRANCE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 579 FRANCE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 580 FRANCE: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 581 SWITZERLAND: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 582 SWITZERLAND: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 583 SWITZERLAND: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 584 SWITZERLAND: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 585 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 586 SWITZERLAND: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 587 SWITZERLAND: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 588 SWITZERLAND: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 589 SWITZERLAND: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 590 SWITZERLAND: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 591 SWITZERLAND: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 592 SWITZERLAND: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 593 SWITZERLAND: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 594 SWITZERLAND: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 595 SWITZERLAND: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 596 ITALY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 597 ITALY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 598 ITALY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 599 ITALY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 600 ITALY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 601 ITALY: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 602 ITALY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 603 ITALY: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 604 ITALY: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 605 ITALY: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 606 ITALY: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 607 ITALY: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 608 ITALY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 609 ITALY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 610 ITALY: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 611 SPAIN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 612 SPAIN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 613 SPAIN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 614 SPAIN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 615 SPAIN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 616 SPAIN: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 617 SPAIN: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 618 SPAIN: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 619 SPAIN: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 620 SPAIN: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 621 SPAIN: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 622 SPAIN: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 623 SPAIN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 624 SPAIN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 625 SPAIN: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 626 REST OF EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 627 REST OF EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 628 REST OF EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 629 REST OF EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 630 REST OF EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 631 REST OF EUROPE: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 632 REST OF EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 633 REST OF EUROPE: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 634 REST OF EUROPE: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 635 REST OF EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 636 REST OF EUROPE: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 637 REST OF EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 638 REST OF EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 639 REST OF EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 640 REST OF EUROPE: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 641 ASIA PACIFIC: PROTEOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 642 ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 643 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 644 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 645 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 646 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 647 ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 648 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 649 ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 650 ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 651 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 652 ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 653 ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 654 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 655 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 656 ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 657 ASIA PACIFIC: KEY MACROINDICATORS
  • TABLE 658 CHINA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 659 CHINA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 660 CHINA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 661 CHINA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 662 CHINA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 663 CHINA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 664 CHINA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 665 CHINA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 666 CHINA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 667 CHINA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 668 CHINA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 669 CHINA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 670 CHINA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 671 CHINA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 672 CHINA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 673 JAPAN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 674 JAPAN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 675 JAPAN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 676 JAPAN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 677 JAPAN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 678 JAPAN: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 679 JAPAN: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 680 JAPAN: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 681 JAPAN: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 682 JAPAN: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 683 JAPAN: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 684 JAPAN: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 685 JAPAN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 686 JAPAN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 687 JAPAN: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 688 INDIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 689 INDIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 690 INDIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 691 INDIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2 022–2029 (USD MILLION)
  • TABLE 692 INDIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 693 INDIA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 694 INDIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 695 INDIA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 696 INDIA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 697 INDIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 698 INDIA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 699 INDIA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 700 INDIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 701 INDIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 702 INDIA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 703 SOUTH KOREA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 704 SOUTH KOREA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 705 SOUTH KOREA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 706 SOUTH KOREA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 707 SOUTH KOREA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 708 SOUTH KOREA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 709 SOUTH KOREA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 710 SOUTH KOREA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 711 SOUTH KOREA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 712 SOUTH KOREA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 713 SOUTH KOREA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 714 SOUTH KOREA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 715 SOUTH KOREA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 716 SOUTH KOREA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 717 SOUTH KOREA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 718 AUSTRALIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 719 AUSTRALIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 720 AUSTRALIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 721 AUSTRALIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 722 AUSTRALIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 723 AUSTRALIA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 724 AUSTRALIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 725 AUSTRALIA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 726 AUSTRALIA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 727 AUSTRALIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 728 AUSTRALIA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 729 AUSTRALIA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 730 AUSTRALIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 731 AUSTRALIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 732 AUSTRALIA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 733 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 734 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 735 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 736 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 737 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 738 REST OF ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 739 REST OF ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 740 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 741 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 742 REST OF ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 743 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 744 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 745 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 746 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 747 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 748 LATIN AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 749 LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 750 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 751 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 752 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 753 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 754 LATIN AMERICA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 755 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 756 LATIN AMERICA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 757 LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 758 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 759 LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 760 LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 761 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 762 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 763 LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 764 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 765 BRAZIL: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 766 BRAZIL: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 767 BRAZIL: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 768 BRAZIL: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 769 BRAZIL: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 770 BRAZIL: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 771 BRAZIL: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 772 BRAZIL: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 773 BRAZIL: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 774 BRAZIL: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 775 BRAZIL: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 776 BRAZIL: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 777 BRAZIL: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 778 BRAZIL: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 779 BRAZIL: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 780 MEXICO: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 781 MEXICO: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 782 MEXICO: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 783 MEXICO: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 784 MEXICO: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 785 MEXICO: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 786 MEXICO: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 787 MEXICO: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 788 MEXICO: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 789 MEXICO: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 790 MEXICO: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 791 MEXICO: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 792 MEXICO: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 793 MEXICO: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 794 MEXICO: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 795 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 796 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 797 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 798 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 799 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 800 REST OF LATIN AMERICA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 801 REST OF LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 802 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 803 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 804 REST OF LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 805 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 806 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 807 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 808 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 809 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 810 MIDDLE EAST: PROTEOMICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 811 MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 812 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 813 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 814 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 815 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 816 MIDDLE EAST: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 817 MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 818 MIDDLE EAST: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 819 MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 820 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 821 MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 822 MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 823 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 824 MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 825 MIDDLE EAST: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 826 MIDDLE EAST: KEY MACROINDICATORS
  • TABLE 827 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 828 GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 829 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 830 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 831 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 832 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 833 GCC COUNTRIES: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 834 GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 835 GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 836 GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 837 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 838 GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 839 GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 840 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 841 GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 842 GCC COUNTRIES: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 843 SAUDI ARABIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 844 SAUDI ARABIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 845 SAUDI ARABIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 846 SAUDI ARABIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 847 SAUDI ARABIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 848 SAUDI ARABIA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 849 SAUDI ARABIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 850 SAUDI ARABIA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 851 SAUDI ARABIA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 852 SAUDI ARABIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 853 SAUDI ARABIA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 854 SAUDI ARABIA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 855 SAUDI ARABIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 856 SAUDI ARABIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 857 SAUDI ARABIA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 858 UAE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 859 UAE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 860 UAE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 861 UAE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 862 UAE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 863 UAE: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 864 UAE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 865 UAE: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 866 UAE: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 867 UAE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 868 UAE: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 869 UAE: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 870 UAE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 871 UAE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 872 UAE: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 873 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 874 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 875 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 876 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 877 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 878 REST OF GCC COUNTRIES: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 879 REST OF GCC COUNTRIES: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 880 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 881 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 882 REST OF GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 883 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 884 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 885 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 886 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 887 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 888 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 889 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 890 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 891 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 892 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 893 REST OF MIDDLE EAST: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 894 REST OF MIDDLE EAST: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 895 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 896 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 897 REST OF MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 898 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 899 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 900 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 901 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 902 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 903 AFRICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 904 AFRICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 905 AFRICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 906 AFRICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 907 AFRICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 908 AFRICA: BIOCHIPS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 909 AFRICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 910 AFRICA: PROTEOMICS MARKET, BY REAGENT, 2022–2029 (USD MILLION)
  • TABLE 911 AFRICA: PROTEOMICS MARKET, BY SERVICE, 2022–2029 (USD MILLION)
  • TABLE 912 AFRICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 913 AFRICA: PROTEOMICS MARKET, BY SOFTWARE, 2022–2029 (USD MILLION)
  • TABLE 914 AFRICA: PROTEOMICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 915 AFRICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 916 AFRICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 917 AFRICA: PROTEOMICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 918 AFRICA: KEY MACROINDICATORS
  • TABLE 919 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEOMICS MARKET
  • TABLE 920 PROTEOMICS MARKET: DEGREE OF COMPETITION
  • TABLE 921 PROTEOMICS MARKET: INSTRUMENTATION TECHNOLOGY FOOTPRINT
  • TABLE 922 PROTEOMICS MARKET: REAGENT FOOTPRINT
  • TABLE 923 PROTEOMICS MARKET: SERVICE FOOTPRINT
  • TABLE 924 PROTEOMICS MARKET: SOFTWARE FOOTPRINT
  • TABLE 925 PROTEOMICS MARKET: REGION FOOTPRINT
  • TABLE 926 PROTEOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 927 PROTEOMICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 928 PROTEOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 929 PROTEOMICS MARKET: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 930 PROTEOMICS MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 931 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 932 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 933 THERMO FISHER SCIENTIFIC INC: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 934 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 935 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 936 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 937 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 938 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 939 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 940 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 941 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 942 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 943 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 944 DANAHER CORPORATION: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 945 SHIMADZU CORPORATION: COMPANY OVERVIEW
  • TABLE 946 SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 947 SHIMADZU CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 948 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 949 WATERS CORPORATION: COMPANY OVERVIEW
  • TABLE 950 WATERS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 951 WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 952 WATERS CORPORATION: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 953 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 954 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 955 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 956 BRUKER: COMPANY OVERVIEW
  • TABLE 957 BRUKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 958 BRUKER: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 959 BRUKER: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 960 REVVITY: COMPANY OVERVIEW
  • TABLE 961 REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 962 REVVITY: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 963 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 964 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 965 ILLUMINA, INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 966 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 967 PROMEGA CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 968 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 969 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 970 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 971 QIAGEN: COMPANY OVERVIEW
  • TABLE 972 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 973 QIAGEN: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 974 QIAGEN: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 975 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 976 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 977 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 978 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 979 PROTAGENE: COMPANY OVERVIEW
  • TABLE 980 PROTAGENE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 981 CREATIVE PROTEOMICS, US: COMPANY OVERVIEW
  • TABLE 982 HORIBA JAPAN LTD.: COMPANY OVERVIEW
  • TABLE 983 SENGENICS CORPORATION LLC: COMPANY OVERVIEW
  • TABLE 984 LABVANTAGE-BIOMAX GERMANY GMBH: COMPANY OVERVIEW
  • TABLE 985 FIOS GENOMICS: COMPANY OVERVIEW
  • TABLE 986 AZENTA US, INC.: COMPANY OVERVIEW
  • TABLE 987 MEDGENOME: COMPANY OVERVIEW
  • TABLE 988 BIOGNOSYS AG: COMPANY OVERVIEW
  • TABLE 989 MACROGEN, INC.: COMPANY OVERVIEW
  • TABLE 990 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 PROTEOMICS MARKET: SEGMENTS CONSIDERED
  • FIGURE 2 PROTEOMICS MARKET: YEARS CONSIDERED
  • FIGURE 3 PROTEOMICS MARKET: RESEARCH DESIGN
  • FIGURE 4 PROTEOMICS MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 8 PROTEOMICS MARKET: MARKET VALIDATION FROM PRIMARY EXPERTS
  • FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 10 PROTEOMICS MARKET: CAGR PROJECTION
  • FIGURE 11 PROTEOMICS MARKET: DATA TRIANGULATION
  • FIGURE 12 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 PROTEOMICS MARKET, BY REAGENT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 PROTEOMICS MARKET, BY SERVICE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 PROTEOMICS MARKET, BY SOFTWARE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 PROTEOMICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 PROTEOMICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 PROTEOMICS MARKET: REGIONAL GROWTH OPPORTUNITIES
  • FIGURE 19 INCREASED R&D INVESTMENTS AND HIGH DEMAND FOR PERSONALIZED MEDICINES TO DRIVE MARKET
  • FIGURE 20 US AND CLINICAL DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PROTEOMICS MARKET IN 2023
  • FIGURE 21 MASS SPECTROMETRY SEGMENT TO DOMINATE MARKET IN 2029
  • FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029
  • FIGURE 23 PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 PERSONALIZED MEDICINES APPROVED BY FDA, 2015–2023
  • FIGURE 25 PROTEOMICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 26 INDICATIVE SELLING PRICE TREND OF PROTEOMICS INSTRUMENTS, BY REGION, 2023 (USD THOUSAND)
  • FIGURE 27 PROTEOMICS PRODUCTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 PROTEOMICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 PROTEOMICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 30 NUMBER OF PATENTS GRANTED ANNUALLY, 2013–2023
  • FIGURE 31 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2013–2023
  • FIGURE 32 PROTEOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 33 KEY BUYING CRITERIA FOR TOP FOUR END USERS
  • FIGURE 34 PROTEOMICS MARKET: IMPACT OF AI/GEN AI
  • FIGURE 35 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: PROTEOMICS MARKET SNAPSHOT
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN PROTEOMICS MARKET (2021–2023)
  • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PROTEOMICS MARKET (2023)
  • FIGURE 39 PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 40 PROTEOMICS MARKET: COMPANY FOOTPRINT
  • FIGURE 41 PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 PROTEOMICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 46 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 47 MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 49 SHIMADZU CORPORATION: COMPANY SNAPSHOT
  • FIGURE 50 WATERS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 52 BRUKER: COMPANY SNAPSHOT
  • FIGURE 53 REVVITY: COMPANY SNAPSHOT
  • FIGURE 54 ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 55 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 56 QIAGEN: COMPANY SNAPSHOT
  • FIGURE 57 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT

This study involved four major activities in estimating the current size of the proteomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and other approaches were employed to estimate the complete market size (proteomics market size). After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the proteomics market. The secondary sources referred to for this research study include publications from government and private sources such as the Indian Pharmaceutical Association (IPA), the Pharmaceutical Research and Manufacturers of America (PhRMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), Central Drugs Standard Control Organization (CDSCO), Indian Brand Equity Foundation (IBEF), European Medicines Agency (EMA), Global Cancer Observatory (GCO), American Chemical Society (ACS), National Center for Biotechnology Information (NCBI), Food and Drug Administration (FDA), Biotechnology and Biological Sciences Research Council (BBSRC), Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Journal of Pharmaceutical Sciences, Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global proteomics market, which was then validated by primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Proteomics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Proteomics Market Size Estimation

A top-down approach was used to estimate and validate the total size of the proteomics market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the total proteomics market size includes the following:

Market Size Estimation Methodology Bottom up approach & Top down Approach

Proteomics Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall proteomics market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Proteomics is the complete evaluation of the structure and function of proteins to understand an organism’s nature. It is the systemic identification and characterization of proteins along with their sequence, abundance, post-translational modifications, interactions, activity, subcellular localization, and structure. The market study includes the assessment of various instruments, reagents, software, and services used in proteomics.

Key Stakeholders

  • Life sciences instrumentation and reagent companies
  • Pharmaceutical and biotechnology companies
  • Proteomics database and software providers
  • Proteomics service providers
  • Research and consulting firms
  • Academic medical centers
  • Government research organizations
  • Clinical research institutes
  • Contract Research Organizations

Report Objectives

  • To define, describe, and forecast the global proteomics market based on the instrumentation technologies, reagents, software & services, application, end-user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall proteomics market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, collaborations, and R&D activities in the proteomics market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographic Analysis

  • Further breakdown of the Rest of Europe proteomics market into respective countries
  • Further breakdown of the Rest of Asia Pacific proteomics market into respective countries
  • Further breakdown of the Rest of Latin America proteomics market into respective countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)
  • An additional five company profiles

Previous Versions of this Report

Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostics, Drug Discovery) End User (Hospital, Labs, Biopharma) - Global Forecast to 2028

Report Code BT 2341
Published in May, 2023, By MarketsandMarkets™

Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecast to 2026

Report Code BT 2341
Published in Mar, 2021, By MarketsandMarkets™

Proteomics Market by Instrument (Spectroscopy, Chromatography, Electrophoresis, Microfluidics, X-ray Crystallography), Reagents, Services & Software (Protein Identification, Characterization, Bioinformatics), Application - Global Forecast to 2024

Report Code BT 2341
Published in Feb, 2019, By MarketsandMarkets™

Proteomics Market - Instrument, Reagent & Service (Spectroscopy, Chromatography, Electrophoresis, Immunoassay, HPLC, X-Ray Crystallography, Mass Spectrometry and Surface Plasmon Resonance) Application (Diagnostics, Drug Discovery) - Forecast to 2021

Report Code BT 2341
Published in Dec, 2016, By MarketsandMarkets™

Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018

Report Code BT 2341
Published in Mar, 2014, By MarketsandMarkets™

Proteomics Market Market by Instruments, Reagents & Services - 2018 | MarketsandMarkets

Report Code BT 2341
Published in Oct, 2012, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Proteomics Market

Gary

Mar, 2022

Looking to gain more insights on the global Proteomics Market.

Nicholas

Mar, 2022

What are the growth opportunities in Proteomics Market?.

Eric

Mar, 2022

Can you enlighten us on geographical growth analysis in Proteomics Market?.

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2025 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status